Nvidia shares rose Wednesday amid rising expectations for the AI chipmaker’s quarterly financial results, due for release after the bell.
Bullish
Why a longtime bull is antsy about stocks, weeks after saying market weakness was a buying opportunity
A once-bullish strategy chief just slashed his bullish rating on US stocks, just weeks after saying to buy the dip. Here’s what changed his
Tesla sales and stock are on the slide. Elon Musk is alienating buyers, one analyst says.
Tesla stock has now fallen by a fifth this year. Analysts say Elon Musk’s involvement with DOGE is affecting sales and investors are taking
Why subdued results from Nvidia could trigger further stock rotation to non-tech sectors
Investors on Wednesday were eagerly awaiting the release of Nvidia Corp.’s earnings report — a pivotal moment for the stock market after the emergence
Still Bullish On Cipher Mining: High-Beta Play On Bitcoin With A Diversified Model
CIFR integrates Bitcoin mining with HPC hosting and strategic power management, targeting 2.6 GW by 2027. Click here to find out why CIFR stock
World Bank bullish on Indian economy: ‘Shining light in the world, best place to invest’
World Bank Country Director Auguste Tano Kouame dismissed worries over short-term fluctuations, calling India “the shining light in the world” and urging global investors
Is The Stock Market Decline That Negative?
As the uncertainty builds investors and traders turn more bearish on stocks but the deep-dive into the data by the Viper Report’s Tom Aspray
Coca-Cola: Strong Momentum Is Bullish But One Headwind Keeps Me From Upgrading
Coca-Cola’s strong Q4 performance and expected 2025 growth are promising. Read more to see why I remain neutral on KO stock.
Here Are Four Potential Bullish Catalysts for Ethereum This Year, According to CryptoQuant CEO Ki Young Ju
Ethereum (ETH) has a flurry of potentially bullish catalysts this year, according to Ki Young Ju, the chief executive of the digital asset analytics
Analysts Are Bullish on Top Healthcare Stocks: Candel Therapeutics (CADL), Day One Biopharmaceuticals (DAWN)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Candel Therapeutics (CADL – Research Report)